Caladan Bio
New York, US · Founded 2023 · 6 known investors
Caladan Bio develops high-throughput benchtop bioreactor hardware and software for laboratory bioprocessing, enabling faster experimentation and lower costs for biotech R&D teams. The company integrates bioreactor equipment with AI-driven process modeling software to support strain optimization and scale-up workflows.
Founders & leadership
MJ
Michael J. KobidaExecutive Officer, Director
RJ
Robert JauquetExecutive Officer, Director
Investors · 6
Reported raises · per SEC filings
Form D private placements▶$5.1MraisedFeb 2024 · 7 investors · Other TechnologyRule 506(b)
▶$5.1MraisedFeb 2024 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. KobidaExecutive Officer, Director
- Robert JauquetExecutive Officer, Director
- Offering amount
- $5.1M
- Amount sold
- $5.1M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- A New Era of Biological Engineering: Investing in Caladan Bio · Collaborative Fundcollabfund.com · 2024
- Please welcome Caladan, the biotech platform changing synthetic biology and biomanufacturing | by Lerer Hippeau | Lerer Hippeau | Mediummedium.com · 2024
- Caladan Bio raises $5m seed round to build next generation benchtop bioreactorsagfundernews.com · 2024
